← Back to Clinical Trials
Recruiting NCT06756646

NCT06756646 Exploring the Effects of Aerobic Exercise Combined with BFRT on Patients with COPD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06756646
Status Recruiting
Phase
Sponsor National Cheng Kung University
Condition Chronic Obstructive Pulmonary Disease
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-11-20
Primary Completion 2028-12-31

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Aerobic exercise interventionDisease and exercise suggestionBlood flow restriction (BFR) intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-11-20 with a primary completion date of 2028-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.

Eligibility Criteria

Inclusion Criteria: 1. COPD classified as levels 2-4. 2. Stable condition without worsening in the past three months. 3. No participation in any rehabilitation program within the past six months. 4. Ability to understand and follow verbal commands and cooperate with an exercise training program. Exclusion Criteria: 1. Unconscious or unable to cooperate with the evaluator. 2. Hospitalization due to acute illness within the past three months. 3. Severe joint diseases or history of lower limb surgery. 4. Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months). 5. Dependence on oxygen supply.

Contact & Investigator

Central Contact

Kun-Ling Tsai, Ph.D.

✉ kunlingtsai@mail.ncku.edu.tw

📞 886-6-2353535

Principal Investigator

Kun-Ling Tsai, Ph.D.

PRINCIPAL INVESTIGATOR

Department of Physical Therapy, National Cheng Kung University

Frequently Asked Questions

Who can join the NCT06756646 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 85 Years, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06756646 currently recruiting?

Yes, NCT06756646 is actively recruiting participants. Contact the research team at kunlingtsai@mail.ncku.edu.tw for enrollment information.

Where is the NCT06756646 trial being conducted?

This trial is being conducted at Tainan, Taiwan.

Who is sponsoring the NCT06756646 clinical trial?

NCT06756646 is sponsored by National Cheng Kung University. The principal investigator is Kun-Ling Tsai, Ph.D. at Department of Physical Therapy, National Cheng Kung University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology